The Pharmacology of Functional, Biochemical, and Recombinant Receptor Systems

Cover
T. Kenakin, J. A. Angus
Springer Science & Business Media, 06.12.2012 - 448 Seiten
This, the 148th volume of the Handbook of Experimental Pharmacology series, focuses on the very core of pharmacology, namely receptor theory. It is fitting that the originator of receptor pharmacology, A. J. CLARK, authored the fourth volume of this series 63 years ago. In that volume CLARK further developed his version of receptor theory first described four years earlier in his classic book The Mode of Action of Drugs. An examination of the topics covered in volume 4 reveals a striking similarity to the topics covered in this present volume; pharmacologists today are still as interested in unlocking the secrets of dose-response relationships to reveal the biological and che mical basis of drug action as they were over half a century ago. Sections in that 1937 volume such as "Curves relating exposure to drugs with biological effects" and "Implications of monomolecular theory" show Clark's keen insight into the essential questions that required answers to move pharma cology forward. With the advent of molecular biological cloning of human receptors has come a transformation of receptor pharmacology. Thus the expression of human receptors into surrogate host cells helped unlock secrets of receptor mechanisms and stimulus-transduction pathways. To a large extent, this elim inates the leap of faith required to apply receptor activity of drugs tested on animal receptor systems to the human therapeutic arena. However, a new leap of faith concerning the veracity of the effects found in recombinant systems with respect to natural ones is now required.
 

Inhalt

Contents
1
Pharmacodynamic Analyses
15
Vascular Reactivity in Human Primary Hypertension
28
Pharmacology of Vascular Conduits for CoronaryBypass
37
References
47
CHAPTER 2
50
Reconciliation
59
H Adenylate Cyclase and αAdrenoceptors
66
Biological Definitions of Efficacy
221
Molecular Definitions of Efficacy
227
E A Stochastic Model of Molecular Efficacy
238
References
254
CHAPTER 9
261
B CoAgonism
267
General Observations
279
Light as the Ligand
287

R University of Texas South Western Medical School
69
CHAPTER 3
73
Is There a Functional role for Cardiac ẞAdrenoceptors?
80
F 5HT4 Receptors
90
G CrossTalk Between Cardiac GCoupled Receptors
95
H Physiological Pathophysiological and Therapeutic Relevance
101
Epilogue
107
New Theoretical Concepts and Molecular Mechanisms
117
Parameters Contributing to Ligand Efficacy
126
Concluding Remarks
143
TwoState Theory
149
F General Application of the Cubic Model
155
G Conclusion
163
Mutations and Diseases of Spontaneous Receptor Activity
173
CHAPTER 7
183
E Limitations of Agonist Potency Ratios
201
H Conclusions
215
Peptides as Ligands
298
Concluding Remarks
302
CHAPTER 11
311
Perspective
328
CHAPTER 12
335
E Conclusions
356
CHAPTER 13
363
G Proteincoupled Receptors
370
376
F Conclusions
383
CHAPTER 14
390
B Use of Reporter Gene Systems in Pharmacology
401
References
412
Melanophore Recombinant Receptor Systems
415
Lawn Format
428
E Summary
435
Urheberrecht

Andere Ausgaben - Alle anzeigen

Häufige Begriffe und Wortgruppen

Bibliografische Informationen